|
C1ORF144 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8079004959759E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.91370252977663E-11 |
| Normal-vs-Stage2 |
4.81310000000068E-06 |
| Normal-vs-Stage3 |
2.014100E-02 |
| Normal-vs-Stage4 |
2.163400E-01 |
| Stage1-vs-Stage2 |
7.884600E-01 |
| Stage1-vs-Stage3 |
1.749000E-01 |
| Stage1-vs-Stage4 |
8.757900E-02 |
| Stage2-vs-Stage3 |
3.320800E-01 |
| Stage2-vs-Stage4 |
1.799000E-01 |
| Stage3-vs-Stage4 |
6.922800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.38470395944546E-11 |
| Normal-vs-AfricanAmerican |
3.78729999583882E-08 |
| Normal-vs-Asian |
5.366200E-02 |
| Caucasian-vs-AfricanAmerican |
6.705400E-01 |
| Caucasian-vs-Asian |
7.322200E-01 |
| AfricanAmerican-vs-Asian |
5.736200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.87248044531452E-12 |
| Normal-vs-Female |
1.421320E-03 |
| Male-vs-Female |
1.800010E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.87430000003963E-06 |
| Normal-vs-Extreme_Weight |
2.02329997200934E-09 |
| Normal-vs-Obese |
4.98869999976392E-07 |
| Normal-vs-Extreme_Obese |
1.155710E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.055600E-01 |
| Normal_Weight-vs-Obese |
9.218000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.481600E-01 |
| Extreme_Weight-vs-Obese |
4.930800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.159800E-01 |
| Obese-vs-Extreme_Obese |
8.008800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.749000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.97699999493884E-08 |
| Normal-vs-Age(61-80Yrs) |
2.28106422639485E-12 |
| Normal-vs-Age(81-100Yrs) |
2.04000000003646E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.684460E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.899000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.176200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.818430E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.664390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.155600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.7334023105775E-11 |
| Normal-VS-Type2 PRCC |
2.51630050129847E-10 |
| Normal-VS-KIRP CIMP |
2.066800E-01 |
| Normal-VS-Unclassified PRCC |
2.009500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.159000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.618500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.684200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.07649999997661E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.811830E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.007900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36670050013777E-10 |
| Normal-vs-N1 |
7.096000E-02 |
| Normal-vs-N2 |
9.905200E-01 |
| N0-vs-N1 |
9.375600E-02 |
| N0-vs-N2 |
2.105500E-02 |
| N1-vs-N2 |
4.586200E-01 |
|
|
